Clinical Impact of Crossover Techniques for Primary Access Hemostasis in Transfemoral Transcatheter Aortic Valve Replacement Procedures

To determine the occurrence of vascular complications (VCs) following transfemoral transcatheter aortic valve replacement (TAVR) with new-generation devices according to the use of a crossover technique (COT). The use of a COT (with/without balloon) has been associated with a reduction of VCs in TAV...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of invasive cardiology 2021-04, Vol.33 (4), p.E302-E311
Hauptverfasser: Junquera, Lucía, Urena, Marina, Latib, Azeem, Muñoz-Garcia, Antonio, Nombela-Franco, Luis, Faurie, Benjamin, Alperi, Alberto, Serra, Vicenç, Regueiro, Ander, Fisher, Quentin, Himbert, Dominique, Mangieri, Antonio, Colombo, Antonio, Muñoz García, Erika, Vera Urquiza, Rafael, Jiménez-Quevedo, Pilar, Pascual, Isaac, Garcia Del Blanco, Bruno, Sabaté, Manel, Mohammadi, Siamak, Freitas-Ferraz, Afonso B, Muntané-Carol, Guillem, Couture, Thomas, Paradis, Jean-Michel, Côté, Melanie, Rodés-Cabau, Josep
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To determine the occurrence of vascular complications (VCs) following transfemoral transcatheter aortic valve replacement (TAVR) with new-generation devices according to the use of a crossover technique (COT). The use of a COT (with/without balloon) has been associated with a reduction of VCs in TAVR patients. However, scarce data support its use with second-generation devices. Also, its potential benefit in obese patients (at high-risk of VCs) has not been elucidated. A multicenter study including 2214 patients who underwent full percutaneous transfemoral TAVR (COT, 1522 patients; no COT, 692 patients). Thirty-day events were evaluated according to the use of a COT using a multivariate logistic regression model. A subanalysis was performed in obese patients. Primary access major VCs (3.5% COT vs 3.9% no COT; P=.19), major/life-threatening bleeding (3.4% COT vs 2.0% no COT; P=.33), and mortality rates (2.4% COT vs 2.6% no COT; P=.23) were similar between groups. However, minor VCs (11.7% COT vs 5.9% no COT; P
ISSN:1557-2501
1557-2501
DOI:10.25270/jic/20.00432